Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interest In Shares

18 Dec 2007 13:35

Oxford Biomedica PLC18 December 2007 For Immediate Release 18 DECEMBER 2007 Oxford BioMedica PLC Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Oxford BioMedica PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( Yes ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): Prudential plc group of companies 4. Full name of shareholder(s) (if different from 3.) (iv): Prudential plc (parent company) M&G Group Limited (wholly owned subsidiary of Prudential plc) M&G Limited (wholly owned subsidiary of M&G Group Limited) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) M&G Securities Limited (wholly owned subsidiary of M&G Limited) The Prudential Assurance Company Limited (wholly owned subsidiary of Prudentialplc) 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 13 December 2007 6. Date on which issuer notified: 17 December 2007 7. Threshold(s) that is/are crossed or reached: 10% 8. Notified details: A: Voting rights attached to shares Class/type of shares if possible using Situation previous to the Triggeringthe ISIN CODE transaction (vi) Number of Number of shares voting Rights (viii)GB0006648157 52,943,339 52,943,339 Resulting situation after the triggering transaction (vii)Class/type of Number of Number of voting rights (ix) % of voting rightsshares if possible sharesusing the ISINCODE Direct Direct (x) Indirect (xi) Direct IndirectGB0006648157 54,488,025 54,488,025 10.19% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Exercise/ Number of voting rights that may % offinancial Date Conversion be acquired if the instrument is votinginstrument (xiii) Period/Date exercised/ converted. rights (xiv) N/A N/A N/A N/A N/A Total (A+B) Number of % of voting voting rights rights 54,488,025 10.19% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Registered Holder Holding % Prudential plc Total Notifiable Interest 54,488,025 10.19% Norturst Nominee Ltd A/C MHF01 134,616 Nortrust Nominee Ltd A/C MKK01 30,342,543 Nortrust Noms Ltd 124,000 PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 5,134,498 M&G Group Limited 54,488,025 10.19% Norturst Nominee Ltd A/C MHF01 134,616 Nortrust Nominee Ltd A/C MKK01 30,342,543 Nortrust Noms Ltd 124,000 PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 5,134,498 M&G Investment ManagementLimited 54,353,409 10.16% Nortrust Nominee Ltd A/C MKK01 30,342,543 Nortrust Noms Ltd 124,000 PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 5,134,498 M&G Limited 54,488,025 10.19% Norturst Nominee Ltd A/C MHF01 134,616 Nortrust Nominee Ltd A/C MKK01 30,342,543 Nortrust Noms Ltd 124,000 PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 5,134,498 M&G Securities Limited 30,477,159 5.70% Norturst Nominee Ltd A/C MHF01 134,616 Nortrust Nominee Ltd A/C MKK01 30,342,543 The Prudential AssuranceCompany Limited 23,886,866 4.46% PRUCLT HSBC GIS NOM (UK) PAC AC 18,750,368 PRUCLT HSBC GIS NOM (UK) PPL AC 5,134,498 Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: Andrew Wood 15. Contact telephone number: 01865 783000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Aug 20199:18 amRNSTotal Voting Rights
25th Jul 20192:17 pmRNSDirector Dealings / Market Share Purchase
1st Jul 201911:04 amEQSHardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
1st Jul 201910:01 amRNSBlock listing Interim Review
1st Jul 20199:32 amRNSTotal Voting Rights
28th Jun 20197:00 amRNSRepayment of Debt Facility
26th Jun 20192:52 pmRNSDirector Dealings / Market Share Purchase
26th Jun 20197:00 amRNSOXB and Santen enter R&D collaboration
25th Jun 20197:00 amRNSBoard Change
18th Jun 20197:15 amEQSHardman & Co Research: Oxford BioMedica (OXB): De-leveraging the balance sheet
10th Jun 20192:34 pmRNSDirector/PDMR Shareholding
6th Jun 20191:08 pmRNSAxovant update on 1st cohort of Sunrise-PD trial
6th Jun 201911:39 amRNSHolding(s) in Company
5th Jun 201912:06 pmRNSHoldings in Company
4th Jun 20195:38 pmRNSHoldings in Company
4th Jun 20199:59 amRNSTotal Voting Rights
3rd Jun 20196:06 pmRNSHolding(s) in Company
3rd Jun 201910:31 amRNSTotal Voting Rights
29th May 20196:19 pmRNSExercise of Subscription Option by Novo Holdings
29th May 20191:06 pmRNSResult of AGM
28th May 20197:00 amRNSStrategic Investment by Novo Holdings A/S
23rd May 20196:04 pmRNSDirector Dealings / Market Share Purchase
2nd May 20192:53 pmRNSLong Term Incentive Plan Option Grant
1st May 201912:52 pmRNSREPLACEMENT: Total Voting Rights
1st May 201911:33 amRNSTotal Voting Rights
30th Apr 20195:38 pmRNSHoldings in Company
30th Apr 20191:35 pmRNSOxford Biomedica to present at the ASGCT
30th Apr 20191:15 pmRNSAxovant doses second cohort of AXO-Lenti-PD
25th Apr 20193:38 pmRNSDirector Dealings / Market Share Purchase
23rd Apr 20191:47 pmRNSDeferred Bonus Plan and LTIP Option Grants
23rd Apr 201911:38 amRNSDirector Dealings / Market Share Transactions
18th Apr 20195:33 pmRNSExercise of warrants
18th Apr 20197:00 amRNSAnnual Report and Accounts & AGM Notification
1st Apr 201911:40 amRNSTotal Voting Rights
26th Mar 201912:57 pmRNSDirector Dealings / Market Share Purchase
26th Mar 20198:25 amRNSJapanese approval of Kymriah® (tisagenlecleucel)
14th Mar 20197:00 amRNSPreliminary Results
12th Mar 20197:00 amRNSOXB announces R&D collaboration with Microsoft
11th Mar 201910:38 amRNSAxovant's update on Phase 2 trial of AXO-Lenti-PD
1st Mar 20199:30 amRNSTotal Voting Rights
25th Feb 201912:23 pmRNSDirector Dealings / Market Share Purchase
8th Feb 20197:00 amRNSNotice of Results
7th Feb 201911:49 amRNSDirector/PDMR Shareholding
7th Feb 20199:22 amRNSUpdate on programmes outlicensed to Sanofi
6th Feb 201911:00 amRNSDirector Dealings / Market Share Transactions
5th Feb 201910:22 amRNSDirector Dealings / Market Share Purchase
1st Feb 201910:00 amRNSTotal Voting Rights
24th Jan 201911:20 amRNSDirector Dealings / Market Share Purchase
3rd Jan 201912:20 pmRNSBlock listing Interim Review
2nd Jan 201910:17 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.